Steris (STE) Sets New 1-Year High at $137.27
Steris PLC (NYSE:STE) shares hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as $137.27 and last traded at $135.80, with a volume of 703500 shares changing hands. The stock had previously closed at $134.76.
A number of research analysts recently issued reports on STE shares. JMP Securities reiterated a “buy” rating and issued a $135.00 price objective on shares of Steris in a report on Thursday, February 14th. Stephens reiterated a “buy” rating and issued a $135.00 price objective on shares of Steris in a report on Thursday, February 14th. Zacks Investment Research lowered shares of Steris from a “hold” rating to a “sell” rating in a report on Wednesday, April 17th. Finally, KeyCorp raised their price objective on shares of Steris from $135.00 to $138.00 and gave the company an “overweight” rating in a report on Wednesday, May 15th. Five analysts have rated the stock with a buy rating, Steris has a consensus rating of “Buy” and an average target price of $145.20.
The firm has a market cap of $11.57 billion, a PE ratio of 27.77 and a beta of 1.06. The company has a current ratio of 2.27, a quick ratio of 1.99 and a debt-to-equity ratio of 0.37.
The company also recently announced a quarterly dividend, which will be paid on Friday, June 28th. Shareholders of record on Wednesday, June 12th will be given a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 1.00%. The ex-dividend date of this dividend is Tuesday, June 11th. Steris’s dividend payout ratio is presently 27.81%.
In other Steris news, CEO Walter M. Rosebrough, Jr. sold 50,000 shares of the stock in a transaction that occurred on Thursday, March 21st. The shares were sold at an average price of $125.00, for a total transaction of $6,250,000.00. Following the completion of the sale, the chief executive officer now owns 98,895 shares of the company’s stock, valued at approximately $12,361,875. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Jacqueline B. Kosecoff sold 3,609 shares of the stock in a transaction that occurred on Wednesday, May 15th. The shares were sold at an average price of $132.22, for a total transaction of $477,181.98. The disclosure for this sale can be found here. Insiders have sold a total of 57,218 shares of company stock valued at $7,166,722 in the last three months. Insiders own 2.38% of the company’s stock.
Large investors have recently added to or reduced their stakes in the business. Pinebridge Investments L.P. acquired a new stake in Steris during the 1st quarter valued at approximately $50,000. Rockefeller Capital Management L.P. acquired a new stake in Steris during the 1st quarter valued at approximately $54,000. Advisory Services Network LLC increased its position in Steris by 26.0% during the 4th quarter. Advisory Services Network LLC now owns 427 shares of the medical equipment provider’s stock valued at $45,000 after purchasing an additional 88 shares during the period. Executive Wealth Management LLC acquired a new stake in Steris during the 4th quarter valued at approximately $47,000. Finally, Enlightenment Research LLC acquired a new stake in Steris during the 4th quarter valued at approximately $53,000. 86.81% of the stock is owned by institutional investors and hedge funds.
Steris Company Profile (NYSE:STE)
STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.
Featured Article: Portfolio Manager
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.